David Meyer

David Meyer is currently the Director of Conjugation at Pfizer Oncology, where they lead a team dedicated to the development of next-generation Antibody Drug Conjugates (ADCs). With over 25 years of biotechnology experience, they previously held positions such as Senior Research Associate at Seattle Genetics and Associate Director at MacroGenics. David also completed a Graduate Research Assistant role at the University of California, Davis, where they investigated cytoskeletal motor proteins. Their expertise spans protein purification, characterization, and cancer biomarker discovery. David continues to play a vital role in advancing cancer therapeutics through innovative research and collaboration.